Article

Interleukin-23 Drives Intestinal Inflammation through Direct Activity on T Cells

Sir William Dunn School of Pathology, University of Oxford, Oxford, OX1 3RE, England, UK.
Immunity (Impact Factor: 19.75). 08/2010; 33(2):279-88. DOI: 10.1016/j.immuni.2010.08.010
Source: PubMed

ABSTRACT Mutations in the IL23R gene are linked to inflammatory bowel disease susceptibility. Experimental models have shown that interleukin-23 (IL-23) orchestrates innate and T cell-dependent colitis; however, the cell populations it acts on to induce intestinal immune pathology are unknown. Here, using Il23r(-/-) T cells, we demonstrated that T cell reactivity to IL-23 was critical for development of intestinal pathology, but not for systemic inflammation. Through direct signaling into T cells, IL-23 drove intestinal T cell proliferation, promoted intestinal Th17 cell accumulation, and enhanced the emergence of an IL-17A(+)IFN-gamma(+) population of T cells. Furthermore, IL-23R signaling in intestinal T cells suppressed the differentiation of Foxp3(+) cells and T cell IL-10 production. Although Il23r(-/-) T cells displayed unimpaired Th1 cell differentiation, these cells showed impaired proliferation and failed to accumulate in the intestine. Together, these results highlight the multiple functions of IL-23 signaling in T cells that contribute to its colitogenic activity.

Download full-text

Full-text

Available from: Chris Schiering, Nov 20, 2014
0 Followers
 · 
137 Views
  • Source
    • "A key role for IL-23 in intestinal inflammation has been demonstrated in both innate and T celldependent experimental models of colitis (Yen et al., 2006; Uhlig et al., 2006). IL-23R signaling in T cells leads to enhanced Th17 accumulation, reduced differentiation of FoxP3 + T cells, and reduced T cell IL-10 production (Ahern et al., 2010). In innate colitis, IL-23 directs expression of IL-17 and induction of pathology via innate lymphoid cells (ILCs) (Buonocore et al., 2010). "
    [Show abstract] [Hide abstract]
    ABSTRACT: NOD2 is an intracellular sensor that contributes to immune defense and inflammation. Here we investigated whether NOD2 mediates its effects through control of microRNAs (miRNAs). miR-29 expression was upregulated in human dendritic cells (DCs) in response to NOD2 signals, and miR-29 regulated the expression of multiple immune mediators. In particular, miR-29 downregulated interleukin-23 (IL-23) by targeting IL-12p40 directly and IL-23p19 indirectly, likely via reduction of ATF2. DSS-induced colitis was worse in miR-29-deficient mice and was associated with elevated IL-23 and T helper 17 signature cytokines in the intestinal mucosa. Crohn's disease (CD) patient DCs expressing NOD2 polymorphisms failed to induce miR-29 upon pattern recognition receptor stimulation and showed enhanced release of IL-12p40 on exposure to adherent invasive E. coli. Therefore, we suggest that loss of miR-29-mediated immunoregulation in CD DCs might contribute to elevated IL-23 in this disease.
    Immunity 09/2013; 39(3):521-36. DOI:10.1016/j.immuni.2013.08.035 · 19.75 Impact Factor
  • Source
    • "IL-23 is mainly expressed by lamina propria DCs in the terminal ileum of normal mice, which relates to the markedly higher frequency of Th17 cells in the intestinal lamina propria than in peripheral lymphoid tissues [91]. Evidence has shown that IL- 23 may have important immune protective effects in the gut, since CD45RB high CD4 + T cells lacking the IL-23R fail to develop into IFN-γ /IL-17A double producers and do not trigger colitis in the T cell transfer model [125]. On the other hand, IL-22 is well known for its role in promoting intestinal barrier integrity. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The gastrointestinal tract is an active player of the human immune system, participating in the innate and adaptive immune responses, keeping the homeostasis of the human being in a healthy status. However, most intestinal conditions are associated with an altered immune response, which implies the activation of CD4(+) T helper (Th) cells. Based on their cytokine secretion, transcription factor expression and immunological functions, the differentiated Th cells were initially subdivided into different lineages: Th1 (that express the transcription factor T-box (T-bet), secrete interferon (IFN)-γ and protect the host against intracellular infections) and Th2 (that express GATA binding protein 3 (GATA-3), secrete interleukin (IL)-4, IL-5 and IL-13, and mediate host defense against helminths). Later, a new subset was identified, the Th17, which selectively produces IL-17A and is crucial for host defense against extracellular pathogens. More recently, a functional plasticity between the Th1 and Th17 lineages has been described, a process sometimes controversial that seems to play a key role in different inflammatory conditions, including those affecting the gastrointestinal system. This review will summarize the current knowledge regarding the regulation and functional role of Th17 cells in the gut, focusing on these newly identified features of this T cell subset, including plasticity, their relationship with regulatory T cells and their heterogeneity in the inflammatory microenvironment. A better understanding of these issues is critical to elucidate the role of Th17 cells in intestine immunity, and so for the design of novel therapeutic approaches for intestinal diseases specifically targeting Th17 cells.
    International Reviews Of Immunology 09/2013; 32(5-6). DOI:10.3109/08830185.2013.834899 · 5.28 Impact Factor
  • Source
    • "In contrast, as in other autoimmune disease models, IL-23 accelerates the severity of murine colitis (Ahern et al. 2010). It is generally believed that IL-17-producing cells are protective but that IL-17/IFN-c double producers are pathogenic and IL-23 accelerates the generation of double producers (Ahern et al. 2010; Hirota et al. 2011). IL-17A is also required for Th2-mediated OVAinduced asthmatic reactions in mice (Nakae et al. 2002). "
    [Show abstract] [Hide abstract]
    ABSTRACT: IL-17-producing T helper (Th17) cells comprise a distinct Th subset involved in epithelial cell- and neutrophil-mediated immune responses against extracellular microbes. At the same time, Th17 cells play significant roles in the development of autoimmune diseases including rheumatoid arthritis and multiple sclerosis. Since the identification of Th17 cells approximately a decade ago, the molecular mechanisms of their differentiation have been intensively studied and a number of signaling cascades and transcription factors have been shown to be involved. Here, we review the current knowledge regarding the function of Th17 cells in vivo as well as several key concepts for the molecular mechanisms of Th17 differentiation. We also discuss the emerging roles of phosphoinositide 3-kinase (PI3K), mammalian target of rapamycin complex 1 (mTORC1) and hypoxia-inducible factor 1 (HIF-1) in the differentiation of Th17 cells.
    Genes to Cells 02/2013; 18(4). DOI:10.1111/gtc.12039 · 2.86 Impact Factor
Show more